Lysteda
- Product NDC
- 55566-2110
- 11-digit product format
- 555662110
- Labeler code
- 55566
- Product ID
- 55566-2110_27bb1a4b-9f87-4b6e-8717-77f1dbd52d2c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tranexamic Acid
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ferring Pharmaceuticals Inc.
- Application
- NDA022430
- Marketing category
- NDA
- Marketing start
- 2010-05-17
- Marketing end
- 2022-12-31
- Substance
- TRANEXAMIC ACID
- Active strength
- 650 mg/1
- Pharmacologic classes
- Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55566-2110-2 | 55566211002 | 30 TABLET in 1 BOTTLE (55566-2110-2) | 30 tablet | 2010-05-17 | 2022-12-31 | No | No | Current |